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SUMMARY
Twenty-four mongrel dogs were subjected to sanguineous and crystalloid cardioplegia for a period of thirty
minutes at 20°C and 2SOC systemic hypothermia during cardiopulmonary bypass. Cardioplegic solutions were
administered at 4°C to induce cardioplegia. Physiological functions of the myocardium revealed that the cardiac
function returned to normal sinus rhythm without any loss when blood cardioplegic solution was used at both
hypothermic temperatures. The time taken for cardioplegia and cardiac electrical quiescence was achieved earlier at 20
"C. Animals in sanguineous cardioplegic group revealed better functional return and revival of cardiac musculature in
terms of lesser applications of defibrillator, lesser requirement of inotropic support and early cardiac contraction. This
study revealed that sanguineous cardioplegic solution at a systemic temperature of 20°C was found to afford better
myocardial protection during an arrest period of 30 minutes.
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INTRODUCTION MATERIALS AND MElHODS
Myocardial ischemic arrest is an essential
requirement during intra-cardiac surgical procedures.
Myocardial preservation during ischemic arrest has been
achieved by topical cooling of the heart musculature or
by the administration of cardioplegic solutions, wherein
the metabolic demands are lowered. The two most popular
methods of pharmacological arrest utilise either blood or
crystalloid solutions as a delivery vehicle. (Axford-Gatley
et al., 1990; Coetzee et al., 1990). Despite the advances in
the composition of the cardioplegic solutions, the
temperature at which it should be delivered and the
method and frequency of administration, a significant
percentage of patients demonstrate clinical evidence of
myocardial damage in the pos-operative period.
This study was conducted to compare crystalloid
and sanguineous cardioplegic solutions using identical
potassium concentrations, identical methods of
administration and identical temperatures of delivery at
two systemic hypothermic temperatures. The objective
was to study the effectiveness of blood and crystalloid
cardioplegic solutions at two different hypothermic
temperatures, the physiologic, haemodynamic and
biochemical changes before, during and after cardioplegic
status and assess the extent of myocardial protection
afforded by the cardioplegic solutions by histo-
pathology.
Twenty four mongrel dogs maintained under identical
feeding and management were used for the study. The













The animals were premedicated with atropine
sulphate (0.05mg/kg) sic and acepromazine (0.1mg/kg) if
m. Anaesthesia was induced with 2.5% thiopentone
sodium (12.5mg/kg) and maintained with isoflurane.
Muscle relaxant pancuroniun bromide (O.lmg/kg) ifv was
administered before connecting the animal to the
ventilator. Ventilation was maintained at a tidal volume of
15ml/kg and the rate was adjusted to 12 breaths/min.
Blood was collected from the donor after cross
matching with the patient for compatibility.
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Preparation of cardioplegic solution
Sanguineous cardioplegic solution was prepared by
obtaining SOOmlof blood from the pump oxygenator to
which 30mEq/L of potassium chloride was added.
Crystalloid cardioplegic solution was prepared by
addition of 30mEq/L potassium chloride, l g of methyl
prednisolone and 16ml ofSO% dextrose to lLofRinger's
solution. The pH of the cardioplegic solutions were
adjusted to a pH of 8 by addition of sodium bicarbonate
solution. The cardioplegic solutions were cooled to 4°C.
(Catinella et al., 1984a).
Priming the bypass circuit
A DIDECO disposable pediatric bubble oxygenator
with heat exchanger and pump was primed with 1300rnl of
lactated Ringers solution and 700ml of blood from the
donor to maintain a haematocrit value of 25%. Sodium
bicarbonate was added to maintain a pH of 7 .3S-7.4S.
Heparin at a total dose of 4000 units and mannitol at Smgl
kg were also added to the priming solution.
Surgical procedure
The heart was approached through a midsternal
incision. Cannulas were placed in the anterior vena cava,
posterior vena cava and the aorta. The animal was then
heparinised at a dose rate of Smg/kg before institution of
cardiopulmonary bypass.
The aortic line from the pump was connected to the
aortic cannula and the venous cannulas to the venous
drainage port of the bubble oxygenator. Perfusion was
maintained to achieve a mean arterial pressure of70-8Smm
ofHg and the flow was adjusted to maintain a flow rate of
70-90mllkg/min. Systemic hypothermia of 20°C or 2SoC
was achieved by circulating chilled water into the
oxygenator. (Ellis et al., 1979; Khuri et al., 1988). The
systemic core temperature was monitored by an
oesophageal temperature probe placed at the level of the
cardia.
On reaching a core temperature of 20°C and 2SoC,
cardioplegia was initiated after cross clamping the aorta
and injecting the cold cardioplegic solutions through a
12 G cardioplegic cannula placed at the aortic root. To
achieve 30 minutes of ischemic arrest, the cardioplegic
solutions were administered at a rate of 10mllkg over a
period of 2-3 minutes. Supplemental doses were
administered as and when electrical activity was observed.
(Baraka et al., 1993). The cardiac arrest period at 20°C or
25°C systemic hypothermia using sanguineous or
crystalloid cardioplegic solutions for 30 minutes was
maintained as a constant factor during the study.
Rewarming and reperfusion was initiated in both the
groups after 30 minutes of cardioplegia by releasing the
aortic cross clamp and raising the temperature of the
circulating blood in the oxygenator to 42°C so as to
achieve a systemic temperature of 38°C. Functional
revival of the myocardium was spontaneous after
rewarming and reperfusion and was assisted by




Heart rate was recorded before thoracotomy, during
open thorax, before cardioplegia, before and 15 minutes
after release of aortic cross clamp.
i) Time for cardioplegia: the time taken in minutes
for cardiac arrest from the time of delivery of
cardioplegic solution.
ii) Time for cardiac electrical quiescence: the duration
in seconds to achieve nil electrical activity after
administration of cardioplegic solutions.
iii) Return and revival of cardiac function
a) Time for appearance of ventricular fibrillation:
the time in seconds taken for appearance of
ventricular fibrillation as the cardioplegic effect
waned off and the systemic temperature
increased.
b) Functional return on rewarming and reperfusion:
the number of hearts that returned to normal
sinus rhythm and the number of hearts that
fibrillated during rewarming and reperfusion.
c) Number of applications of defibrillator: the
number of applications of defibrillator on the
fibrillating hearts.
d) Inotropic support: the number of hearts
requiring inotropic support after cross clamp
removal.
iv) Time for cardiac contraction: the time in minutes
taken for the appearance of normal cardiac
contractions after cardioplegia.
v) Time for sinus rhythm: The time taken, in minutes,
for appearance of normal sinus rhythm.
vi) Volume of cardioplegic solution delivered: the
volume in milliliters of cardioplegic solutions
required for 30 minutes of cardioplegia.
vii) Electrocardiography: electrocardiographs were
recorded using the standard limb leads for
continuous monitoring of myocardial activity.
II. Haemodynamics
i) Mean arterial pressure was recorded through the
femoral artery cannulation and central venous
pressure was recorded through jugular vein
cannulation before thoracotomy, at open thorax
and IS minutes after release of aortic cross clamp.
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ii) Left Ventricular Pressure: systolic and diastolic
pressure of the left ventricle was recorded through
a cannula placed in the left ventricle at open thorax,
before bypass, after resumption of sinus rhythm
and 15minutes after reperfusion.
iii) Coronary sinus effluent recovered and flow rate:
coronary sinus effluent was collected through a
cannula placed in the right atrium from the time of
delivery of cardioplegic solution till the end of
cardioplegia.
The coronary effluent flow rate was determined as
per the formula:
CEFR =Coronary effluent (in ml) x
____ ~1____ x 100
Min. of cardioplegia Wet wt of heart
III. Biochemical
i) Systemic
Partial pressure of oxygen and carbon dioxide
tension and serum enzymes - creatine
phosphokinase, lactate dehydrogenase and
aspartate amino transferase were estimated before
thoracotomy, after thoracotomy, during bypass
and 15 minutes after reperfusion.
ii) Coronary
Partial pressure of oxygen and carbon dioxide
tension and coronary enzymes - creatine
phosphokinase, creatine kinase isoenzyme-MB
and lactate were estimated at 15th and 30th minute
of cardioplegia.
IV. Myocardial Water Content
Myocardial water content was estimated by
harvesting the hearts after 15 minutes of reperfusion by
the formula:
Wet Wt - Dry Wt x 100
WetWt
V. Histopathology
Transmural sections of left ventricle fixed in 10%
buffered formalin and stained with hematoxylin and eosin
were examined for presence of markers of myocyte damage
such as contraction band necrosis, hyper-eosinophilia
or smudging of myofibrils with loss of cytoplasmic details.
The data were subjected to equal or unequal completely
randomised design and analysed statistically.
RESULTS AND DISCUSSION
Physiological-cardiac function
Irrespective of the systemic hypothermic
temperatures, the heart rate in all the animals in Group I
returned to normal sinus rhythm 15 minutes after release
of aortic cross clamp, whereas only four hearts at 20°C
and five hearts at 25°C systemic hypothermia returned
to functional status in Group II. The better functional
return of hearts in the sanguineous group can be
attributed to the presence of red blood cells which
protected the myocardium against reperfusion injury by
increased oxygen delivery and the presence of protein
which buffered the oxygen free radical metabolites (Van
Asbecketal.,1975).
The mean time taken to achieve cardioplegia in
seconds was 15.00±0.83, 19.04±0.78, 18.60±1.09 and
21.18±0.73 in subgroups A and B in Groups I and II
respectively. Statistical analysis indicated a decrease in
the time taken for cardioplegia in subgroup A in Groups I
and II and may be due to lower systemic hypothermia
resulting in lowered metabolic demands of the hearts
(Maloney and Nelson, 1975; Standeven et al., 1979).
Cardiac electrical quiescence was achieved at a
shorter period of time with 20°C systemic hypothermia.
The average time in seconds was 18.61±0.73, 21.00±0.76,
20.24±0.77 and 24.03± 1.09 in subgroups A and B in Groups
I and II respectively. The quicker electrical quiescence at
20°C in both groups and with sanguineous cardioplegia
may be due to the presence of intrinsic potassium in the
blood cardioplegic solution which altered the movement
of intracellular potassium and thereby altering the
electrical gradient across the cell membrane (Surawicz,
1980; Cunningham et al., 1979).
The time for appearance of ventricular fibrillation was
significantly lesser at 20°C hypothermia in both the
groups. Five hearts and three hearts in subgroup A and
B of Group I returned spontaneously to functional mode
while only two hearts in subgroup A and one heart in
subgroup B in Group II were functional. Though the
number of applications of the defibrillator was not
statistically significant between the groups, it was lesser
in Group I.Inotropic support was instituted after attempts
to defibrillate failed. The number of animals that required
inotropic support was 1,0,3 and 3 in subgroups A and B
of Group I and II respectively. The time taken for cardiac
contraction to appear after rewarming showed no
significant change in either groups whereas, the time taken
for sinus rhythm to appear was significantly lesser in
Group I. The results of the study revealed better
functional return and revival of cardiac musculature when
sanguineous cardioplegic solution at 20°C was used in
terms of lesser applications of the defibrillator, lesser
requirement of inotropic support, early cardiac contraction
and appearance of sinus rhythm (Cunnigham et al., 1979;
Acar et al., 1991a; 1991b; Kofsky et al., 1991; Robinson
and Harwood, 1991; Brown et al., 1993).
The volume of cardioplegic solution required for
thirty minutes of cardioplegia was 306.56± 12.4,
324.29±5.ll, 358.40± 10.59 and 369. 72±6.93 milliliters in
subgroups A and B of Groups I and II respectively.
Statistical analysis revealed that a significantly higher
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volume of crystalloid cardioplegic solution was required
for 30 minutes of ischemic arrest. The lower volume of
sanguineous cardioplegic solution required maybe due
to its cellular content apart from the intrinsic contents in
blood that were able to meet the metabolic demands of
the myocytes during ischemia (Surawicz, 1980).
Following rewarming and reperfusion, ventricular
tachyarrhythmia of electrocardiographic configurations
were observed. The ventricular fibrillations were
frequently accompanied by ventricular extra systoles and
sinus beats. In the sanguineous group, the ectopic
ventricular complex was interrupted by the T wave of the
preceding complex. Fifteen minutes following reperfusion,
an increase in the width of the P wave and elongation of
the QRS complex was evident. The P-R interval was also
increased accompanied by elongated Q- T interval.
Ventricular fibrillation following aortic cross clamp release
may be due to hypoxia and release of catecholamines
resulting in increased influx of calcium (Meesmann et al.,
1976; Pollock,1977).
Haemodynamics
The mean arterial pressure revealed a significant
decrease during open thorax and was comparable with
the mean pressure after release of aortic cross clamp.
The mean arterial pressure after 15 minutes ofreperfusion
at 20°C in the blood cardioplegia group improved
indicating better maintenance of cardiac contractility,
preservation of high energy phosphates and decreased
lactic acid accumulation during the anaerobic arrest. The
findings concurred with the findings of Coetzee et al.,
1990; Shragge et al., 1978; Panos et al., 1990.
The central venous pressure was elevated at open
thorax when compared to the base values. At 15 minutes
after reperfusion, the pressure was significantly higher
than at open thorax in both the groups. The elevation in
central venous pressure after release of aortic cross clamp
release may be due to over-hydration during bypass.
(Kofsky et al., 1991).
The mean left ventricular systolic and diastolic
pressures showed an insignificant increase at both the
hypothermic temperatures when sanguineous
cardioplegia was used. Sanguineous cardioplegia
afforded greater protection to the myocardium by
preventing ischemia and infarction and providing
increased capillary blood flow, maintaining oxygen
demand-supply ratio and thereby providing energy to
the reviving myocardial cells (Ko et al., 1992).
The mean coronary effluent flow rate was 5.32±0.34,
5.67±0.35, 6.95±0.41 and 6.98±0.32 milliliters per lOOG of
heart per minute in subgroups A and B of Groups I and II
respectively. Statistical analysis revealed a higher
coronary effluent flow rate with crystalloid cardioplegic
solution when compared to sanguineous cardioplegic
solution. The increased flow rate in the crystalloid group
can be attributed to the reactive hyperemia which
followed ischemia and the lower flow rate with
sanguineous cardioplegic solution to increased viscosity
of blood at lower temperatures and the high coronary
vascular resistance during hypothermia (O'Neill et al.,
198; Catinella et al., 1984). Crystalloid cardioplegia at
25°C hypothermia revealed higher retention because of
lower vascular resistance (Acar et al., 1991) damage to
the endothelial lining (Saldhana and Hearse, 1989) and
inadequate myocardial protection resulting in myocardial
edema (Feindel et al., 1984).
Biochemical
1. Systemic - blood gas and enzymes
The mean systemic partial pressure of oxygen was
significantly higher in subgroups A when compared to
subgroups B in Groups I and II. After reperfusion, Group
I animals had a higher arterial oxygen tension than Group
II animals. The partial pressure of carbondioxide also
showed a significant increase after thoracotomy in both
the groups. The increased carbondixoide tension during
bypass may be attributed to atelectasis of alveoli and
increased pulmonary hypotension. The higher arterial
oxygen tension at 20°C hypothermic temperature during
bypass may be due to reduced tissue metabolism and the
decreased affinity of tissues to attract oxygen (Catinella
et al., 1984a; Axford-Gatley et al., 1990).
The systemic creatine phosphokinase levels showed
a significant increase during bypass and 15 minutes after
reperfusion and the mean values were significantly higher
in Group I than in Group II. The increase can be attributed
to the tissue damage caused to skeletal muscles during
thoracotomy, suboptimal oxygen utilisation and
myocardial ischemia (Goto, 1974). When comparing the
means of sanguineous and crystalloid cardioplegia, the
levels were higher in the latter indicating lesser protection
during global ischemia (Cerra et al., 1975; Ahumada et
al., 1976).
A significant increase in the mean lactate
dehydrogenase level was evident during the various
stages. However, after 15 minutes of reperfusion a peak
LDH value was observed in subgroup B of Group I
followed by subgroup B of Group II, subgroup A of Group
I and subgroup A of Group II. LDH is not specific to any
tissue but is released extracellularly during cell damage.
The LDH release was more pronounced at 25°C and may
be due to higher oxygen demand at 25°C and decreased
availability of oxygen (Brown et al., 1993).
The analysis of variance showed a significant
increase (P< 0.0 I) in the mean aspartate amino transferase
level during bypass in all the subgroups. However,
subgroup B of Groups I and II maintained significantly
high enzyme levels. Higher levels of aspartate amino
transferase at 25°C systemic hypothermia could be due
to higher oxygen requirement than at 20°C. Thomas and
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Kurt (1979) attributed this elevation to a reduction in
blood flow, hypotension and transient hypoxemia.
2. Coronary - blood gas and enzymes
The mean partial pressure of oxygen in the coronary
sinus effluent ranged between 290.34± I 0.80 and
292.62± 13.43 in the sanguineous group and between
164.14±5.95 and 165.83±6.20 in the crystalloid group. The
partial pressure of oxygen in the coronary sinus effluent
was significantly high and the oxygen extraction by the
myocardium (P02 of cardioplegic solution minus P02 of
coronary effluent) was increased with sanguineous
cardioplegic solution. The sanguineous cardioplegic
solution contained oxygen in both the dissolved and
hemoglobin-bound state and may be the reason for the
elevated values (Warner et al., 1987).
No significant change in the mean carbondioxide
tension was evident in the two cardioplegic solution
groups. However, the levels were higher in Group II at
15th and 30th minute of cardioplegia suggesting higher
level of ongoing anaerobic metabolism in the myocardium
(Bing et al., 1982; Feindal et al., 1984; Kofsky et al.,
1991).
The coronary effluent creatine phosphokinase
leakage exhibited a significant progressive increase as
the duration of ischemia advanced up to 30th minute of
cardioplegia in the crystalloid cardioplegic group and is
attributed to the conversion of aerobic to anaerobic
metabolic pathways in the myocardial cells (Gray et al.,
1977). However the increase was mild in the blood
cardioplegic group because of the presence of oxygen
for aerobic metabolism to continue and synthesise high
energy phosphates.
Creatine kinase isoenzyme MB considered as the
most sensitive and specific marker of myocardial injury
increased significantly in subgroup B of Group II followed
by subgroup B of Group I and subgroup A of Group II.
This indicates that at 25°C systemic hypothermic
temperature, both the cardioplegic solutions offered
lesser protection to the myocardium (Yau et al., 1993).
Analysis of variance revealed a significant decrease
in the mean lactate level with sanguineous solution when
compared to crystalloid solution. The mean lactate level
progressively increased significantly at 15th and 30th
minutes with crystalloid cardioplegia. Lactate being the
end product of anaerobic glycolytic metabolic pathway,
was lower in the ????when blood cardioplegia was used.
As the sanguineous solution provided the required
quantity of oxygen during ischemia, lactate release was
negligible (Warner et al., 1987).
The mean percentage of myocardial water content
was 78.83±0.22, 78.86±0.27, 80.34±0.86 and 81.0 I±0.37 in
subgroups A and B if Groups I and II respectively. Oxygen
delivery to the myocardium is comparatively lesser with
crystalloid cardioplegic solution leading to an increase
in the production of oxygen free radicals which triggers
inflammatory response in the ischemic myocardium.
Myocardial hypoxia has also been incriminated for the
higher myocardial water content. Edema of the
myocardium may also be due retention of cardioplegic
solution in the crystalloid group which correlated with
the higher coronary sinus effluent flow rate (Tabayashi
etal.,1991).
Histopathology
The histopathological examination of sections ofleft
ventricle revealed markers of myocyte damage with both
the groups at 20°C and 25°C systemic hypothermia. In
subgroup A of Group I, very few areas of myocyte injury
could be identified. The ratio of fields exhibiting markers
of myocyte damage such as hypereosinophilia was only
30:5. In subgroup B of Group I, in eight out of thirty fields
examined, mild myofibrillar smudging and eosinophilic
infiltration in the myocardium could be detected.
Myocardial sections in Group II animals showed
hypereosinophilic infiltration and extensive loss of
striations of myofibrils. These markers of injury were at
the ratio of 30: lOin subgroup A and 30: 14 in subgroup B.
Severe myocardial edema was also evident in all the group
II hearts.
The presence of mild eosinophilic infiltration in
Group I might be attributed to inflammation of the
myocytes during ischemia and after reperfusion resulting
from change in temperature and substrate (Brown et al.,
1993). The severe myocyte damage in Group II may be
due to the lack of oxygen carrying capacity of the
crystalloid solution (Barner, 1991; Cunningham et al.,
1979).
CONCLUSION
Sanguineous cardioplegia delivered at 4°C at a
systemic hypothermic temperature of 20°C provided
adequate myocardial protection and early return to
function during total heart-lung bypass in dogs.
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